Intravenous infusion of the beta-3 adrenergic receptor antagonist APD418 improves left ventricular function in dogs with systolic heart failure despite long-term therapy with beta-blockers

Authors

Hani N. Sabbah, Henry Ford HealthFollow
Kefei Zhang, Henry Ford HealthFollow
Jiang Xu, Henry Ford HealthFollow
Ramesh C. Gupta, Henry Ford HealthFollow
N. Nguyen
J. Adams

Recommended Citation

Sabbah HN, Zhang K, Xu J, Gupta RC, Nguyen N, and Adams J. Intravenous infusion of the beta-3 adrenergic receptor antagonist APD418 improves left ventricular function in dogs with systolic heart failure despite long-term therapy with beta-blockers. Eur J Heart Fail 2022; 24:104-104.

Document Type

Conference Proceeding

Publication Date

7-2022

Publication Title

Eur J Heart Fail

Volume

24

First Page

104